ThermoGenesis Holdings, Inc. (THMO)

Market Cap	16.00
Revenue (ttm)	9.61M
Net Income (ttm)	-14.75M
Shares Out	15.85M
EPS (ttm)	-4.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55
Average Volume	135
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-14.85
RSI	6.35
Earnings Date	Aug 8, 2025

About ThermoGenesis Holdings

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 25
• Stock Exchange: OTCMKTS
• Ticker Symbol: THMO

Financial Performance

In 2023, ThermoGenesis Holdings's revenue was $9.45 million, a decrease of -9.90% compared to the previous year's $10.48 million. Losses were -$17.98 million, 59.5% more than in 2022.